Evaluation of chronic kidney disease in chronic heart failure: From biomarkers to arterial renal resistances
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Evaluation of chronic kidney disease in chronic heart failure: From biomarkers to arterial renal resistances
  • 作者:Massimo ; Iacoviello ; Marta ; Leone ; Valeria ; Antoncecchi ; Marco ; Matteo ; Ciccone
  • 英文作者:Massimo Iacoviello;Marta Leone;Valeria Antoncecchi;Marco Matteo Ciccone;Cardiology Unit,Cardiothoracic Department, University Hospital Policlinico Consorziale of Bari, 70124 Bari, Italy;Department of Emergency and Organ Transplantation, University of Bari, 70124 Bari, Italy;
  • 英文关键词:Heart failure;;Biomarkers;;Doppler;;Renal resistance index;;Chronic kidney disease
  • 中文刊名:LCBG
  • 英文刊名:世界临床病例报告杂志(英文版)
  • 机构:Cardiology Unit,Cardiothoracic Department,University Hospital Policlinico Consorziale of Bari, 70124 Bari, Italy;Department of Emergency and Organ Transplantation, University of Bari, 70124 Bari, Italy;
  • 出版日期:2015-01-16
  • 出版单位:World Journal of Clinical Cases
  • 年:2015
  • 期:v.3
  • 语种:英文;
  • 页:LCBG201501002
  • 页数:10
  • CN:01
  • 分类号:19-28
摘要
Chronic kidney disease and its worsening are recurring conditions in chronic heart failure(CHF) which are independently associated with poor patient outcome.The heart and kidney share many pathophysiological mechanisms which can determine dysfunction in each organ. Cardiorenal syndrome is the condition in which these two organs negatively affect each other, therefore an accurate evaluation of renal function in the clinical setting of CHF is essential. This review aims to revise the parameters currently used to evaluate renal dysfunction in CHF with particular reference to the usefulness and the limitations of biomarkers in evaluating glomerular dysfunction and tubular damage. Moreover, it is reported the possible utility of renal arterial resistance index(a parameter associated with abnormalities in renal vascular bed) for a better assesment of kidney disfunction.
        Chronic kidney disease and its worsening are recurring conditions in chronic heart failure(CHF) which are independently associated with poor patient outcome.The heart and kidney share many pathophysiological mechanisms which can determine dysfunction in each organ. Cardiorenal syndrome is the condition in which these two organs negatively affect each other, therefore an accurate evaluation of renal function in the clinical setting of CHF is essential. This review aims to revise the parameters currently used to evaluate renal dysfunction in CHF with particular reference to the usefulness and the limitations of biomarkers in evaluating glomerular dysfunction and tubular damage. Moreover, it is reported the possible utility of renal arterial resistance index(a parameter associated with abnormalities in renal vascular bed) for a better assesment of kidney disfunction.
引文
1 Hillege HL,Girbes AR,de Kam PJ,Boomsma F,de Zeeuw D,Charlesworth A,Hampton JR,van Veldhuisen DJ.Renal function,neurohormonal activation,and survival in patients with chronic heart failure.Circulation 2000;102:203-210[PMID:10889132]
    2 Smith GL,Lichtman JH,Bracken MB,Shlipak MG,Phillips CO,Di Capua P,Krumholz HM.Renal impairment and outcomes in heart failure:systematic review and metaanalysis.J Am Coll Cardiol 2006;47:1987-1996[PMID:16697315DOI:10.1016/j.jacc.2005.11.084]
    3 Damman K,Jaarsma T,Voors AA,Navis G,Hillege HL,van Veldhuisen DJ.Both in-and out-hospital worsening of renal function predict outcome in patients with heart failure:results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure(COACH).Eur J Heart Fail 2009;11:847-854[PMID:19696057 DOI:10.1093/eurjhf/hfp108]
    4 Ronco C,Haapio M,House AA,Anavekar N,Bellomo R.Cardiorenal syndrome.J Am Coll Cardiol 2008;52:1527-1539[PMID:19007588 DOI:10.1016/j.jacc.2008.07.051]
    5 Ronco C,Ronco F.Cardio-renal syndromes:a systematic approach for consensus definition and classification.Heart Fail Rev 2012;17:151-160[PMID:21197571 DOI:10.1007/s10741-010-9224-0]
    6 Ronco C,Di Lullo L.Cardiorenal syndrome.Heart Fail Clin 2014;10 :251-280[PMID:24656104 DOI:10.1016/j.hfc.2013.12.003]
    7 Damman K,Navis G,Smilde TD,Voors AA,van der Bij W,van Veldhuisen DJ,Hillege HL.Decreased cardiac output,venous congestion and the association with renal impairment in patients with cardiac dysfunction.Eur J Heart Fail 2007;9:872 -878[PMID:17586090 DOI:10.1016/j.ejheart.2007.05.010]
    8 Iacoviello M,Puzzovivo A,Monitillo F,Saulle D,Lattarulo MS,Guida P,Forleo C,Gesualdo L,Favale S.Independent role of high central venous pressure in predicting worsening of renal function in chronic heart failure outpatients.Int J Cardiol 2013;162:261-263[PMID:22805552 DOI:10.1016/j.ijcard.2012.06.088]
    9 Stevens LA,Coresh J,Greene T,Levey AS.Assessing kidney function--measured and estimated glomerular filtration rate.N Engl J Med 2006;354:2473-2483[PMID:16760447]
    10 Mc Murray JJ,Adamopoulos S,Anker SD,Auricchio A,Bhm M,Dickstein K,Falk V,Filippatos G,Fonseca C,Gomez-Sanchez MA,Jaarsma T,Kber L,Lip GY,Maggioni AP,Parkhomenko A,Pieske BM,Popescu BA,Rnnevik PK,Rutten FH,Schwitter J,Seferovic P,Stepinska J,Trindade PT,Voors AA,Zannad F,Zeiher A,Bax JJ,Baumgartner H,Ceconi C,Dean V,Deaton C,Fagard R,Funck-Brentano C,Hasdai D,Hoes A,Kirchhof P,Knuuti J,Kolh P,McD onagh T,Moulin C,Popescu BA,Reiner Z,Sechtem U,Sirnes PA,Tendera M,Torbicki A,Vahanian A,Windecker S,Mc Donagh T,Sechtem U,Bonet LA,Avraamides P,Ben Lamin HA,Brignole M,Coca A,Cowburn P,Dargie H,Elliott P,Flachskampf FA,Guida GF,Hardman S,Iung B,Merkely B,Mueller C,Nanas JN,Nielsen OW,Orn S,Parissis JT,Ponikowski P.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012:The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure2012 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association(HFA)of the ESC.Eur J Heart Fail 2012;14:803-869[PMID:22828712 DOI:10 .1093/eurjhf/hfs105]
    11 Ferguson MA,Waikar SS.Established and emerging markers of kidney function.Clin Chem 2012;58:680-689[PMID:22311920 DOI:10.1373/clinchem.2011.167494]
    12 Smilde TD,van Veldhuisen DJ,Navis G,Voors AA,Hillege HL.Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction.Circulation 2006;114:1572-1580[PMID:17015793 DOI:10.1161/CIRCULATIONAHA]
    13 Levey AS,Stevens LA,Schmid CH,Zhang YL,Castro AF,Feldman HI,Kusek JW,Eggers P,Van Lente F,Greene T,Coresh J.A new equation to estimate glomerular filtration rate.Ann Intern Med 2009;150:604-612[PMID:19414839 DOI:10 .7326/0003-4819-150-9-200905050-00006]
    14 Stevens LA,Schmid CH,Greene T,Zhang YL,Beck GJ,Froissart M,Hamm LL,Lewis JB,Mauer M,Navis GJ,Steffes MW,Eggers PW,Coresh J,Levey AS.Comparative performance of the CKD Epidemiology Collaboration(CKD-EPI)and the Modification of Diet in Renal Disease(MDRD)Study equations for estimating GFR levels above 60mL/min/1.73 m2.Am J Kidney Dis 2010;56:486-495[PMID:20557989 DOI:10.1053/j.ajkd.2010.03.026]
    15 Matsushita K,Mahmoodi BK,Woodward M,Emberson JR,Jafar TH,Jee SH,Polkinghorne KR,Shankar A,Smith DH,Tonelli M,Warnock DG,Wen CP,Coresh J,Gansevoort RT,Hemmelgarn BR,Levey AS.Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.JAMA 2012;307:1941-1951[PMID:22570462 DOI:10.1001/jama.2012.3954]
    16 Valente MA,Hillege HL,Navis G,Voors AA,Dunselman PH,van Veldhuisen DJ,Damman K.The Chronic Kidney Disease Epidemiology Collaboration equation outperforms the Modification of Diet in Renal Disease equation for estimating glomerular filtration rate in chronic systolic heart failure.Eur J Heart Fail 2014;16:86-94[PMID:23901055 DOI:10 .1093/eurjhf/hft128]
    17 McA lister FA,Ezekowitz J,Tarantini L,Squire I,Komajda M,Bayes-Genis A,Gotsman I,Whalley G,Earle N,Poppe KK,Doughty RN.Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction:impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula.Circ Heart Fail 2012;5:309-314[PMID:22441773 DOI:10.1161/CIRCHEARTFAILURE.111.966242]
    18 Damman K,Navis G,Voors AA,Asselbergs FW,Smilde TD,Cleland JG,van Veldhuisen DJ,Hillege HL.Worsening renal function and prognosis in heart failure:systematic review and meta-analysis.J Card Fail 2007;13:599-608[PMID:17923350 DOI:10.1016/j.cardfail.2007.04.008]
    19 Smith GL,Shlipak MG,Havranek EP,Masoudi FA,McC lellan WM,Foody JM,Rathore SS,Krumholz HM.Race and renal impairment in heart failure:mortality in blacks versuswhites.Circulation 2005;111:1270-1277[PMID:15769768 DOI:10 .116110.1161/01.CIR.0000158131]
    20 Akhter MW,Aronson D,Bitar F,Khan S,Singh H,Singh RP,Burger AJ,Elkayam U.Effect of elevated admission serum creatinine and its worse ningnout come in hospitalized patients with decompensated heart failure.Am J Cardiol 2004;94:957-960[PMID:15464689 DOI:10.1016/j.amjcard.2004.06.041]
    21 Khan NA,Ma I,Thompson CR,Humphries K,Salem DN,Sarnak MJ,Levin A.Kidney function and mortality among patients with left ventricular systolic dysfunction.J Am Soc Nephrol 2006;17:244-253[PMID:16291840 DOI:10.1681/ASN.2005030270]
    22 Krumholz HM,Chen YT,Vaccarino V,Wang Y,Radford MJ,Bradford WD,Horwitz RI.Correlates and impact on outcomes of worsening renal function in patients>or=65 years of age with heart failure.Am J Cardiol 2000;85:1110-1113[PMID:10781761]
    23 Metra M,Nodari S,Parrinello G,Bordonali T,Bugatti S,Danesi R,Fontanella B,Lombardi C,Milani P,Verzura G,Cotter G,Dittrich H,Massie BM,Dei Cas L.Worsening renal function in patients hospitalised for acute heart failure:clinical implications and prognostic significance.Eur J Heart Fail 2008;10:188-195[PMID:18279773 DOI:10.1016/j.ejheart.2008.01.011]
    24 Stevens PE,Levin A.Evaluation and management of chronic kidney disease:synopsis of the kidney disease:improving global outcomes 2012 clinical practice guideline.Ann Intern Med 2013;158:825-830[PMID:23732715 DOI:10.7326/0003-4819-158-11-201306040-00007]
    25 Damman K,Voors AA,Navis G,van Veldhuisen DJ,Hillege HL.Current and novel renal biomarkers in heart failure.Heart Fail Rev 2012;17:241-250[PMID:21604178 DOI:10.1007/s10741-011-9254-2]
    26 Bosch JP.Renal reserve:a functional view of glomerular filtration rate.Semin Nephrol 1995;15:381-385[PMID:8525139]
    27 Laterza OF,Price CP,Scott MG.Cystatin C:an improved estimator of glomerular filtration rateClin Chem 2002;48:699 -707[PMID:11978596]
    28 Singh D,Whooley MA,Ix JH,Ali S,Shlipak MG.Association of cystatin C and estimated GFR with inflammatory biomarkers:the Heart and Soul Study.Nephrol Dial Transplant2007;22:1087-1092[PMID:17210589 DOI:10.1093/ndt/gfl744]
    29 Fricker M,Wiesli P,Brndle M,Schwegler B,Schmid C.Impact of thyroid dysfunction on serum cystatin C.Kidney Int 2003;63:1944-1947[PMID:12675875 DOI:10.1046/j.1523-1755.2003.00925.x]
    30 Dharnidharka VR,Kwon C,Stevens G.Serum cystatin C is superior to serum creatinine as a marker of kidney function:a meta-analysis.Am J Kidney Dis 2002;40:221-226[PMID:12148093 DOI:10.1054/ajkd.2002.34487]
    31 Hoek FJ,Kemperman FA,Krediet RT.A comparison between cystatin C,plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate.Nephrol Dial Transplant 2003;18:2024-2031[PMID:13679476DOI:10.1093/ndt/gfg349]
    32 Shlipak MG,Mattes MD,Peralta CA.Update on cystatin C:incorporation into clinical practice.Am J Kidney Dis 2013;62:595 -603[PMID:23701892 DOI:10.1053/j.ajkd.2013.03.027]
    33 Lassus J,Harjola VP.Cystatin C:a step forward in assessing kidney function and cardiovascular risk.Heart Fail Rev 2012;17 :251-261[PMID:21431356 DOI:10.1007/s10741-011-9242-6]
    34 Inker LA,Schmid CH,Tighiouart H,Eckfeldt JH,Feldman HI,Greene T,Kusek JW,Manzi J,Van Lente F,Zhang YL,Coresh J,Levey AS.Estimating glomerular filtration rate from serum creatinine and cystatin C.N Engl J Med 2012;367:20 -29[PMID:22762315 DOI:10.1056/NEJMoa1114248]
    35 Shlipak MG,Sarnak MJ,Katz R,Fried LF,Seliger SL,Newman AB,Siscovick DS,Stehman-Breen C.Cystatin C andthe risk of death and cardiovascular events among elderly persons.N Engl J Med 2005;352:2049-2060[PMID:15901858DOI:10.1056/NEJMoa043161]
    36 Ix JH,Shlipak MG,Chertow GM,Whooley MA.Association of cystatin C with mortality,cardiovascular events,and incident heart failure among persons with coronary heart disease:data from the Heart and Soul Study.Circulation2007;115:173-179[PMID:17190862DOI:10.1161/CIRCULATIONAHA.106.644286]
    37 Sarnak MJ,Katz R,Stehman-Breen CO,Fried LF,Jenny NS,Psaty BM,Newman AB,Siscovick D,Shlipak MG.Cystatin C concentration as a risk factor for heart failure in older adults.Ann Intern Med 2005;142:497-505[PMID:15809461 DOI:10 .7326/0003-4819-142-7-200504050-00008]
    38 Arimoto T,Takeishi Y,Niizeki T,Takabatake N,Okuyama H,Fukui A,Tachibana H,Nozaki N,Hirono O,Tsunoda Y,Miyashita T,Shishido T,Takahashi H,Koyama Y,Kubota I.Cystatin C,a novel measure of renal function,is an independent predictor of cardiac events in patients with heart failure.J Card Fail 2005;11:595-601[PMID:16230262DOI:10.1016/j.cardfail.2005.06.001]
    39 Alehagen U,Dahlstrm U,Lindahl TL.Cystatin C and NT-pro BNP,a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure:results from a 10-year study in primary care.Eur J Heart Fail 2009;11:354-360[PMID:19228797 DOI:10 .1093/eurjhf/hfp024]
    40 Tang WH,Van Lente F,Shrestha K,Troughton RW,Francis GS,Tong W,Martin MG,Borowski AG,Jasper S,Starling RC,Klein AL.Impact of myocardial function on cystatin C measurements in chronic systolic heart failure.J Card Fail 2008;14:394-399[PMID:18514931 DOI:10.1016/j.cardfail.2008.01.006]
    41 Miller WG,Bruns DE,Hortin GL,Sandberg S,Aakre KM,Mc Queen MJ,Itoh Y,Lieske JC,Seccombe DW,Jones G,Bunk DM,Curhan GC,Narva AS.Current issues in measurement and reporting of urinary albumin excretion.Clin Chem 2009;55:24-38[PMID:19028824 DOI:10.1373/clinchem.2008.106567]
    42 van der Velde M,Matsushita K,Coresh J,Astor BC,Woodward M,Levey A,de Jong P,Gansevoort RT,van der Velde M,Matsushita K,Coresh J,Astor BC,Woodward M,Levey AS,de Jong PE,Gansevoort RT,Levey A,El-Nahas M,Eckardt KU,Kasiske BL,Ninomiya T,Chalmers J,Macmahon S,Tonelli M,Hemmelgarn B,Sacks F,Curhan G,Collins AJ,Li S,Chen SC,Hawaii Cohort KP,Lee BJ,Ishani A,Neaton J,Svendsen K,Mann JF,Yusuf S,Teo KK,Gao P,Nelson RG,Knowler WC,Bilo HJ,Joosten H,Kleefstra N,Groenier KH,Auguste P,Veldhuis K,Wang Y,Camarata L,Thomas B,Manley T.Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality.A collaborative meta-analysis of high-risk population cohorts.Kidney Int 2011;79:1341-1352[PMID:21307840 DOI:10.1038/ki.2010.536]
    43 van de Wal RM,Asselbergs FW,Plokker HW,Smilde TD,Lok D,van Veldhuisen DJ,van Gilst WH,Voors AA.High prevalence of microalbuminuria in chronic heart failure patients.J Card Fail 2005;11:602-606[PMID:16230263 DOI:10 .1016/j.cardfail.2005.05.007]
    44 Niizeki T,Takeishi Y,Sasaki T,Kaneko K,Sugawara S,Watanabe T,Kubota I.Usefulness of albuminuria as a prognostic indicator in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.Am J Cardiol 2013;111:1180-1186[PMID:23351461 DOI:10 .1016/j.amjcard.2012.12.050]
    45 Kriz W,Le Hir M.Pathways to nephron loss starting from glomerular diseases-insights from animal models.Kidney Int 2005;67:404-419[PMID:15673288 DOI:10.1111/j.1523-1755.2005.67097.x]
    46 Gerstein HC,Mann JF,Yi Q,Zinman B,Dinneen SF,Hoogwerf B,HalléJP,Young J,Rashkow A,Joyce C,Nawaz S,Yusuf S.Albuminuria and risk of cardiovascular events,death,and heart failure in diabetic and nondiabetic individuals.JAMA 2001;286:421-426[PMID:11466120 DOI:10.1001/jama.286.4.421]
    47 Damman K,van Deursen VM,Navis G,Voors AA,van Veldhuisen DJ,Hillege HL.Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease.J Am Coll Cardiol 2009;53:582-588[PMID:19215832 DOI:10.1016/j.jacc.2008.08.080]
    48 Damman K,Masson S,Hillege HL,Voors AA,van Veldhuisen DJ,Rossignol P,Proietti G,Barbuzzi S,Nicolosi GL,Tavazzi L,Maggioni AP,Latini R.Tubular damage and worsening renal function in chronic heart failure.JACC Heart Fail 2013;1:417 -424[PMID:24621973 DOI:10.1016/j.jchf.2013.05.007]
    49 Jackson CE,Solomon SD,Gerstein HC,Zetterstrand S,Olofsson B,Michelson EL,Granger CB,Swedberg K,Pfeffer MA,Yusuf S,Mc Murray JJ.Albuminuria in chronic heart failure:prevalence and prognostic importance.Lancet 2009;374:543 -550[PMID:19683640 DOI:10.1016/S0140-6736(09)61378-7]
    50 Masson S,Latini R,Milani V,Moretti L,Rossi MG,Carbonieri E,Frisinghelli A,Minneci C,Valisi M,Maggioni AP,Marchioli R,Tognoni G,Tavazzi L.Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure:data from the GISSI-Heart Failure trial.Circ Heart Fail 2010;3:65-72[PMID:19850697 DOI:10.1161/CIRCHEARTFAILURE]
    51 Damman K,Hillege HL,van Veldhuisen DJ.Albuminuria in heart failure:a CHARMing new risk factorLancet 2009;374:506 -508[PMID:19683628 DOI:10.1016/S0140-6736(09)61469-0]
    52 Schmidt-Ott KM,Mori K,Li JY,Kalandadze A,Cohen DJ,Devarajan P,Barasch J.Dual action of neutrophil gelatinaseassociated lipocalin.J Am Soc Nephrol 2007;18:407-413[PMID:17229907 DOI:10.1681/ASN.2006080882]
    53 Mori K,Lee HT,Rapoport D,Drexler IR,Foster K,Yang J,Schmidt-Ott KM,Chen X,Li JY,Weiss S,Mishra J,Cheema FH,Markowitz G,Suganami T,Sawai K,Mukoyama M,Kunis C,D’Agati V,Devarajan P,Barasch J.Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury.J Clin Invest 2005;115 :610-621[PMID:15711640 DOI:10.1172/JCI200523056]
    54 Schmidt-Ott KM,Mori K,Kalandadze A,Li JY,Paragas N,Nicholas T,Devarajan P,Barasch J.Neutrophil gelatinaseassociated lipocalin-mediated iron traffic in kidney epithelia.Curr Opin Nephrol Hypertens 2006;15:442-449[PMID:16775460 DOI:10.1097/01.mnh.0000232886]
    55 Bazzi C,Petrini C,Rizza V,Arrigo G,Napodano P,Paparella M,D’Amico G.Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.Nephrol Dial Transplant 2002;17:1890-1896[PMID:12401843 DOI:10 .1093/ndt/17.11.1890]
    56 Wellwood JM,Ellis BG,Price RG,Hammond K,Thompson AE,Jones NF.Urinary N-acetyl-beta-D-glucosaminidase activities in patients with renal disease.Br Med J 1975;3:408 -411[PMID:1156788]
    57 Han WK,Bailly V,Abichandani R,Thadhani R,Bonventre JV.Kidney Injury Molecule-1(KIM-1):a novel biomarker for human renal proximal tubule injury.Kidney Int 2002;62:237-244[PMID:12081583 DOI:10.1046/j.1523-1755.2002.00433.x]
    58 Meijer E,Boertien WE,Nauta FL,Bakker SJ,van Oeveren W,Rook M,van der Jagt EJ,van Goor H,Peters DJ,Navis G,de Jong PE,Gansevoort RT.Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease:a cross-sectional analysis.Am J Kidney Dis 2010;56:883-895[PMID:20888104 DOI:10.1053/j.ajkd.2010.06.023]
    59 Han WK,Alinani A,Wu CL,Michaelson D,Loda M,Mc Govern FJ,Thadhani R,Bonventre JV.Human kidneyinjury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma.J Am Soc Nephrol 2005;16:1126-1134[PMID:15744000 DOI:10.1681/ASN.2004070530]
    60 Haase M,Bellomo R,Devarajan P,Ma Q,Bennett MR,Mckel M,Matalanis G,Dragun D,Haase-Fielitz A.Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults.Ann Thorac Surg 2009;88:124-130[PMID:19559209 DOI:10.1016/j.athoracsur.2009.04.023]
    61 Haase M,Bellomo R,Devarajan P,Schlattmann P,HaaseFielitz A.Accuracy of neutrophil gelatinase-associated lipocalin(NGAL)in diagnosis and prognosis in acute kidney injury:a systematic review and meta-analysis.Am J Kidney Dis 2009;54:1012-1024[PMID:19850388 DOI:10.1053/j.ajkd.2009.07.020]
    62 Mishra J,Dent C,Tarabishi R,Mitsnefes MM,Ma Q,Kelly C,Ruff SM,Zahedi K,Shao M,Bean J,Mori K,Barasch J,Devarajan P.Neutrophil gelatinase-associated lipocalin(NGAL)as a biomarker for acute renal injury after cardiac surgery.Lancet 2005;365:1231-1238[PMID:15811456 DOI:10 .1016/S0140-6736(05)74811-X]
    63 Parikh CR,Coca SG,Thiessen-Philbrook H,Shlipak MG,Koyner JL,Wang Z,Edelstein CL,Devarajan P,Patel UD,Zappitelli M,Krawczeski CD,Passik CS,Swaminathan M,Garg AX.Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery.J Am Soc Nephrol 2011;22:1748-1757[PMID:21836143 DOI:10 .1681/ASN.2010121302]
    64 Choudhary R,Gopal D,Kipper BA,De La Parra Landa A,Aramin H,Lee E,Shah S,Maisel AS.Cardiorenal biomarkers in acute heart failure.J Geriatr Cardiol 2012;9:292-304[PMID:23097660 DOI:10.3724/SP.J.1263.2012.02291]
    65 Alvelos M,Loureno P,Dias C,Amorim M,Rema J,Leite AB,Guimares JT,Almeida P,Bettencourt P.Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure.Int J Cardiol 2013;165:51-55[PMID:21872946]
    66 Dupont M,Shrestha K,Singh D,Awad A,Kovach C,Scarcipino M,Maroo AP,Tang WH.Lack of significant renal tubular injury despite acute kidney injury in acute decompensated heart failure.Eur J Heart Fail 2012;14:597-604[PMID:22505396 DOI:10.1093/eurjhf/hfs039]
    67 Collins SP,Hart KW,Lindsell CJ,Fermann GJ,Weintraub NL,Miller KF,Roll SN,Sperling MI,Sawyer DB,Storrow AB.Elevated urinary neutrophil gelatinase-associated lipocalcin after acute heart failure treatment is associated with worsening renal function and adverse events.Eur J Heart Fail 2012;14:1020-1029[PMID:22733980 DOI:10.1093/eurjhf/hfs087]
    68 Testani JM,Tang WH.Biomarkers of acute kidney injury in chronic heart failure:what do the signals meanJACC Heart Fail 2013;1:425-426[PMID:24621974 DOI:10.1016/j.jchf.2013.08.001]
    69 Damman K,van Veldhuisen DJ,Navis G,Voors AA,Hillege HL.Urinary neutrophil gelatinase associated lipocalin(NGAL),a marker of tubular damage,is increased in patients with chronic heart failure.Eur J Heart Fail 2008;10:997-1000[PMID:18804416 DOI:10.1016/j.ejheart.2008.07.001]
    70 Damman K,Van Veldhuisen DJ,Navis G,Vaidya VS,Smilde TD,Westenbrink BD,Bonventre JV,Voors AA,Hillege HL.Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate.Heart 2010;96:1297-1302[PMID:20659949 DOI:10.1136/hrt.2010.194878]
    71 Damman K,Masson S,Hillege HL,Maggioni AP,Voors AA,Opasich C,van Veldhuisen DJ,Montagna L,Cosmi F,Tognoni G,Tavazzi L,Latini R.Clinical outcome of renal tubular damage in chronic heart failure.Eur Heart J 2011;32:2705-2712[PMID:21666249 DOI:10.1093/eurheartj/ehr190]
    72 Parikh CR,Jani A,Melnikov VY,Faubel S,Edelstein CL.Urinary interleukin-18 is a marker of human acute tubular necrosis.Am J Kidney Dis 2004;43:405-414[PMID:14981598]
    73 Parikh CR,Mishra J,Thiessen-Philbrook H,Dursun B,MaQ,Kelly C,Dent C,Devarajan P,Edelstein CL.Urinary IL-18is an early predictive biomarker of acute kidney injury after cardiac surgery.Kidney Int 2006;70:199-203[PMID:16710348DOI:10.1038/sj.ki.5001527]
    74 Mallat Z,Heymes C,Corbaz A,Logeart D,Alouani S,CohenSolal A,Seidler T,Hasenfuss G,Chvatchko Y,Shah AM,Tedgui A.Evidence for altered interleukin 18(IL)-18 pathway in human heart failure.FASEB J 2004;18:1752-1754[PMID:15371332 DOI:10.1096/fj.04-2426fje]
    75 Niizeki T,Takeishi Y,Arimoto T,Nozaki N,Hirono O,Watanabe T,Nitobe J,Miyashita T,Miyamoto T,Koyama Y,Kitahara T,Suzuki S,Sasaki T,Kubota I.Persistently increased serum concentration of heart-type fatty acidbinding protein predicts adverse clinical outcomes in patients with chronic heart failure.Circ J 2008;72:109-114[PMID:18159110]
    76 Chade AR.Renal vascular structure and rarefaction.Compr Physiol 2013;3:817-831[PMID:23720331 DOI:10.1002/cphy.c120012]
    77 Winton FR.The influence of venous pressure on the isolated mammalian kidney.J Physiol 1931;72:49-61[PMID:16994199]
    78 Mullens W,Abrahams Z,Francis GS,Sokos G,Taylor DO,Starling RC,Young JB,Tang WH.Importance of venous congestion for worsening of renal function in advanced decompensated heart failure.J Am Coll Cardiol 2009;53:589 -596[PMID:19215833 DOI:10.1016/j.jacc.2008.05.068]
    79 Jessup M,Costanzo MR.The cardiorenal syndrome:do we need a change of strategy or a change of tacticsJ Am Coll Cardiol 2009;53:597-599[PMID:19215834 DOI:10.1016/j.jacc.2008.11.012]
    80 Pourcelot L.Velocimetrie ultrasonore Doppler.Seminaire INSERM.Paris,France:Edition INSERM,1974:213-240
    81 Parolini C,Noce A,Staffolani E,Giarrizzo GF,Costanzi S,Splendiani G.Renal resistive index and long-term outcome in chronic nephropathies.Radiology 2009;252:888-896[PMID:19528356 DOI:10.1148/radiol.2523080351]
    82 Tublin ME,Bude RO,Platt JF.Review.The resistive index in renal Doppler sonography:where do we standAJR Am J Roentgenol 2003;180:885-892[PMID:12646425]
    83 Platt JF,Ellis JH,Rubin JM,DiP ietro MA,Sedman AB.Intrarenal arterial Doppler sonography in patients with nonobstructive renal disease:correlation of resistive index with biopsy findings.AJR Am J Roentgenol 1990;154:1223-1227[PMID:2110732]
    84 Ikee R,Kobayashi S,Hemmi N,Imakiire T,Kikuchi Y,Moriya H,Suzuki S,Miura S.Correlation between the resistive index by Doppler ultrasound and kidney function and histology.Am J Kidney Dis 2005;46:603-609[PMID:16183414 DOI:10.1053/j.ajkd.2005.06.006]
    85 Hanamura K,Tojo A,Kinugasa S,Asaba K,Fujita T.The resistive index is a marker of renal function,pathology,prognosis,and responsiveness to steroid therapy in chronic kidney disease patients.Int J Nephrol 2012;2012:139565[PMID:23304501 DOI:10.1155/2012/139565]
    86 Sugiura T,Nakamori A,Wada A,Fukuhara Y.Evaluation of tubulointerstitial injury by Doppler ultrasonography in glomerular diseases.Clin Nephrol 2004;61:119-126[PMID:14989631]
    87 Sugiura T,Wada A.Resistive index predicts renal prognosis in chronic kidney disease.Nephrol Dial Transplant 2009;24:2780-2785[PMID:19318356 DOI:10.1093/ndt/gfp121]
    88 Boddi M,Cecioni I,Poggesi L,Fiorentino F,Olianti K,Berardino S,La Cava G,Gensini G.Renal resistive index early detects chronic tubulointerstitial nephropathy in normo-and hypertensive patients.Am J Nephrol 2006;26:16-21[PMID:16401882]
    89 Ciccone MM,Iacoviello M,Gesualdo L,Puzzovivo A,Antoncecchi V,Doronzo A,Monitillo F,Citarelli G,Paradies V,Favale S.The renal arterial resistance index:a marker of renal function with an independent and incremental role in predicting heart failure progression.Eur J Heart Fail 2014;16:210 -216[PMID:24464953 DOI:10.1002/ejhf.34]
    90 Ennezat PV,Maréchaux S,Six-Carpentier M,Pinon C,Sediri I,Delsart P,Gras M,Mounier-Véhier C,Gautier C,Montaigne D,Jude B,Asseman P,Le Jemtel TH.Renal resistance index and its prognostic significance in patients with heart failure with preserved ejection fraction.Nephrol Dial Transplant 2011;26 :3908-3913[PMID:21421591 DOI:10.1093/ndt/gfr116]
    91 Monitillo F,Iacoviello M.Citarelli G,Leone M.Independentand incremental role of renal resistance index in predicting mortality among heart failure outpatients.Eur J of Heart Fail2014;16:126
    92 Citarelli G,Iacoviello M,Monitillo F,Leone M.A high renal arterial resistance index is associated to one year worsening of renal function in heart failure outpatients.Eur J of Heart Fail 2014;16:126

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700